Sector News

Novozymes appoints Ester Baiget from Dow as new CEO

October 31, 2019
Chemical Value Chain

Enzymes maker Novozymes said on Wednesday it had appointed Ester Baiget from Dow as the firm looks to boost its sales growth on the back of several profit warnings.

Baiget is currently business president of Dow’s Industrial Solutions business unit and will take over the reins at the Danish firm from February 2020.

Novozymes, which has repeatedly cut it 2019 sales outlook, said earlier this month that current CEO Peder Holk Nielsen would step down as it was time to “bring in new leadership”.

By Andreas Mortensen

Source: Reuters

Join the discussion!

Your email address will not be published. Required fields are marked *

Related News

January 16, 2021

INEOS reduces planned Antwerp investment

Chemical Value Chain

LinkedIn Twitter Xing EmailINEOS has postponed work on the propane dehydrogenation (PDH) unit at its Antwerp, Belgium site, opting to prioritise construction of the cracker, a company spokesperson said on […]

January 10, 2021

TechnipFMC resumes plans to split company

Chemical Value Chain

TechnipFMC says it has resumed activities related to the previous announced separation of the company into two separate pure-play businesses, TechnipFMC and Technip Energies.

January 10, 2021

Solvay’s extended maternity, paternity & co-parent policy goes into effect

Chemical Value Chain

Solvay’s new policy increases maternity leave to 16 weeks. It is now available to any co-parent regardless of gender or sexual orientation; it also includes parents who adopt. The parent employed by Solvay will receive 100% of his or her salary during this leave period.

Send this to a friend